Brad L. Tade - Jul 24, 2024 Form 3 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
CFO and Treasurer
Signature
/s/ Brad L. Tade, by Adam S. Grossman as attorney-in-fact
Stock symbol
ADMA
Transactions as of
Jul 24, 2024
Transactions value $
$0
Form type
3
Date filed
7/26/2024, 09:00 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ADMA Common Stock 17K Jul 24, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ADMA Restricted Stock Units Jul 24, 2024 Common Stock 75K $0.00 Direct F2
holding ADMA Restricted Stock Units Jul 24, 2024 Common Stock 50K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares acquired in open market purchases and pursuant to the vesting of restricted stock units ("RSUs").
F2 On June 26, 2023, the Issuer granted the reporting person 100,000 RSUs, 75,000 of which are currently unvested, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting. Of the 25,000 RSUs that vested on June 26, 2024, 9,838 shares were withheld by the Issuer to satisfy mandatory tax withholding requirements.
F3 On February 26, 2024, the Issuer granted the reporting person 50,000 RSUs, all of which are currently unvested, with 25% vesting on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, which RSUs will be settled into common stock upon vesting.

Remarks:

Exhibit 24 - Power of Attorney